MedTrace Logo

A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State

NCT01563497 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2012-03-27

No results posted yet for this study

Summary

The primary purpose of this study is to estimate the relative bioavailability and food effect of a PF-05089771 tablet.

Conditions

Interventions

DRUG

PF-05089771

Oral dispersion TS formulation- fasted

DRUG

PF-05089771

Tablets TS formulation- fasted

DRUG

PF-05089771

Tablets TS formulation- fed

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01563497 on ClinicalTrials.gov